?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

Katie Quinn

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
February 12, 2019 Katie Quinn
The Biosimilars Forum Objects to Consolidate Billing of Biosimilars
News
February 1, 2019 Katie Quinn
The Biosimilar Forum Recognizes Leah Christl’s Departure from FDA
News
January 31, 2019 Katie Quinn
The Biosimilars Forum Applauds HHS Proposal to Target Costly Rebates Structure Blocking Patients from Biosimilars and Savings
News
December 13, 2018 Katie Quinn
The Biosimilars Forum Commends FDA for Commitment to Increase Patient Access to Biosimilars
News
December 4, 2018 Katie Quinn
Biosimilars Forum Statement on Citizen Petition to the Food and Drug Administration
News
December 3, 2018 Katie Quinn
Biosimilars Forum Announces Launch of Biosimilars Roundtable
News
October 10, 2018 Katie Quinn
New White Paper Finds Biosimilars Could Drive Greater Value Beyond Price for Healthcare System
News
August 9, 2018 Katie Quinn
Biosimilars Forum Statement on CMS Announcement Regarding Medicare Advantage
News
July 18, 2018 Katie Quinn
Biosimilars Forum Applauds Biosimilars Action Plan Released by FDA Commissioner Scott Gottlieb
News
July 16, 2018 Katie Quinn
Biosimilars Forum Submits Comments on HHS Blueprint to Lower Drug Prices
  • Prev page
  • 01
  • 02
  • 03
  • 04
  • 05
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us